The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma (RRMM) and prior B-cell maturation antigen (BCMA)-directed therapies: A pooled analysis from MagnetisMM studies.
 
Ajay K. Nooka
Honoraria - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb/Celgene; Cellectar; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; ONK Therapeutics; Pfizer; Secura Bio; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb; Cellectar; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; ONK Therapeutics; Pfizer; Secura Bio; Takeda
Research Funding - Amgen (Inst); Arch Oncology (Inst); Bristol-Myers Squibb/Celgene (Inst); Cellectar (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Alexander M. Lesokhin
Honoraria - ITeos Therapeutics; Janssen; Legend Biotech; Pfizer; Sanofi; Trillium Therapeutics
Consulting or Advisory Role - Pfizer; Trillium Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc
 
Mohamad Mohty
Honoraria - Amgen; Astellas Pharma; Bristol-Myers Squibb; Celgene
Research Funding - Jazz Pharmaceuticals
 
Ruben Niesvizky
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Takeda
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Takeda
 
Christopher Maisel
Consulting or Advisory Role - ADC Therapeutics; Blueprint Medicines; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Kite, a Gilead Company
 
Bertrand Arnulf
Honoraria - Celgene; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Sanofi
Research Funding - Janssen-Cilag
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen-Cilag; Takeda
 
Sarah Marie Larson
Stock and Other Ownership Interests - 1200 Pharma; Torl Biotherapeutics
Consulting or Advisory Role - Oncovalent Therapeutics
Research Funding - Abbvie; Allogene Therapeutics (Inst); BiolineRx; Bristol-Myers Squibb; Celgene; Janssen Oncology; Novartis; Pfizer (Inst); Sanofi (Inst)
 
Asya Varshavsky Yanovsky
Consulting or Advisory Role - BMS; GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - US patent 9155781
 
Xavier P Leleu
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; GlaxoSmithKline; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Merck; Novartis; Oncopeptides; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Merck; Novartis; Oncopeptides; Roche; Takeda
Travel, Accommodations, Expenses - Takeda
 
Lionel Karlin
Employment - Aguettant (I)
Honoraria - Abbvie; Abbvie; Amgen; Celgene; Janssen-Cilag; sanofi; sanofi; Takeda
Consulting or Advisory Role - Abbvie; Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
Travel, Accommodations, Expenses - Amgen; Janssen-Cilag; Sanofi; Takeda
 
David H. Vesole
Stock and Other Ownership Interests - Abbvie; Amgen; Biogen; Bristol-Myers Squibb; Gilead Sciences; Johnson & Johnson; Lilly; Merck; Novartis; Sorrento Therapeutics
Consulting or Advisory Role - Cellectar; Janssen
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Sanofi; Takeda
 
Nizar J. Bahlis
Honoraria - Abbvie; Amgen; Celgene; Genentech/Roche; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Research Funding - Celgene (Inst); Janssen (Inst)
 
Carlos Fernández de Larrea
Honoraria - Amgen; BeiGene; Bristol-Myers Squibb/Celgene; Janssen; Pfizer
Consulting or Advisory Role - Amgen; BeiGene; Bristol-Myers Squibb/Celgene; Janssen; Pfizer; Sanofi
Research Funding - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Janssen
 
Noopur S. Raje
Honoraria - Amgen; Bristol-Myers Squibb; Janssen; Medscape; Research to Practice
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen
Research Funding - 2seventy bio
 
Eric Leip
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Umberto Conte
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Mohamed Elmeliegy
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Andrea Viqueira
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Salomon Manier
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Celgene/Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst)